The purpose of this study is to evaluate the ocular safety and efficacy of a glaucoma drug delivery system in open-angle glaucoma or ocular hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
55
inserted for 14 days
inserted for 14 days
inserted for 14 days
Unnamed facility
Artesia, California, United States
Unnamed facility
Louisville, Kentucky, United States
Unnamed facility
Baltimore, Maryland, United States
Unnamed facility
Mt. Pleasant, South Carolina, United States
Visual Acuity - Right Eye
This outcome measures visual acuity in logMARs. logMAR is the logarithm of the minimum angle of resolution (logMAR). The ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.
Time frame: at 14 days
Visual Acuity - Left Eye
This outcome measures visual acuity in logMARs. logMAR is the logarithm of the minimum angle of resolution (logMAR. The ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.
Time frame: at 14 days
Intraocular Pressure (IOP)
Time frame: from baseline to 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.